BR0213583A - Processo para preparar um composto de insulina, e, composto de insulina - Google Patents

Processo para preparar um composto de insulina, e, composto de insulina

Info

Publication number
BR0213583A
BR0213583A BR0213583-3A BR0213583A BR0213583A BR 0213583 A BR0213583 A BR 0213583A BR 0213583 A BR0213583 A BR 0213583A BR 0213583 A BR0213583 A BR 0213583A
Authority
BR
Brazil
Prior art keywords
insulin compound
insulin
preparing
compound
ester
Prior art date
Application number
BR0213583-3A
Other languages
English (en)
Inventor
Are Bogsnes
Ingun Christiansen
Per Balschmidt
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR0213583A publication Critical patent/BR0213583A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"PROCESSO PARA PREPARAR UM COMPOSTO DE INSULINA, E, COMPOSTO DE INSULINA". Um caminho preferido de converter precursores de insulina em compostos de insulina é realizar uma clivagem de peptídeo enzimática em um meio aquoso e, depois disso, sem remoção do produto intermediário formado, adicionar um éster de aminoácido ou um éster de peptídeo e um solvente orgânico para que a ligação desejada ocorra.
BR0213583-3A 2001-11-19 2002-11-15 Processo para preparar um composto de insulina, e, composto de insulina BR0213583A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101716 2001-11-19
PCT/DK2002/000765 WO2003044210A2 (en) 2001-11-19 2002-11-15 Process for preparing insulin compounds

Publications (1)

Publication Number Publication Date
BR0213583A true BR0213583A (pt) 2004-08-24

Family

ID=8160841

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0213583-3A BR0213583A (pt) 2001-11-19 2002-11-15 Processo para preparar um composto de insulina, e, composto de insulina

Country Status (15)

Country Link
EP (1) EP1448786B1 (pt)
JP (1) JP4404631B2 (pt)
KR (1) KR100925381B1 (pt)
CN (1) CN100424179C (pt)
AT (1) ATE464390T1 (pt)
AU (1) AU2002342597A1 (pt)
BR (1) BR0213583A (pt)
CA (1) CA2464616C (pt)
DE (1) DE60236014D1 (pt)
ES (1) ES2344448T3 (pt)
HU (1) HU228934B1 (pt)
IL (2) IL161358A0 (pt)
PL (1) PL210437B1 (pt)
RU (1) RU2376379C2 (pt)
WO (1) WO2003044210A2 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006031962A1 (de) * 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Amidiertes Insulin Glargin
DE102006031955A1 (de) 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
TW200902708A (en) * 2007-04-23 2009-01-16 Wyeth Corp Methods of protein production using anti-senescence compounds
HUE037449T2 (hu) 2008-10-17 2018-08-28 Sanofi Aventis Deutschland Egy inzulin és egy GLP-1 agonista kombinációja
MX346473B (es) * 2009-08-11 2017-03-22 Biocon Ltd Procesos cromatograficos y compuestos purificados de los mismos.
PE20121316A1 (es) 2009-11-13 2012-10-05 Sanofi Aventis Deutschland Composicion farmaceutica que comprende un agonista de glp-1 y metionina
RU2537239C2 (ru) 2009-11-13 2014-12-27 Санофи-Авентис Дойчланд Гмбх Фармацевтическая композиция, включающая агонист glp-1, инсулин и метионин
PT2611458T (pt) 2010-08-30 2016-12-16 Sanofi Aventis Deutschland Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PT2750699E (pt) 2011-08-29 2015-11-03 Sanofi Aventis Deutschland Acelerómetro pendular
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
CN102703552B (zh) * 2012-05-15 2014-10-29 山东阿华生物药业有限公司 重组人胰岛素的制备方法及其产品
CN102816819B (zh) * 2012-08-13 2014-10-29 山东阿华生物药业有限公司 提高人胰岛素前体融合蛋白酶切转换成b30缺苏氨酸人胰岛素产率的方法
CN103305581B (zh) * 2013-07-04 2015-05-27 珠海联邦制药股份有限公司 一种重组人胰岛素的制备方法
MY177247A (en) * 2013-12-23 2020-09-10 Biocon Biologics Ltd Method of production of human insulin methyl ester
CA2970200A1 (en) 2014-12-12 2016-06-16 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
US20180291077A1 (en) * 2015-09-24 2018-10-11 Hanmi Pharm. Co., Ltd Method of insulin production

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE50892B1 (en) 1980-02-11 1986-08-06 Novo Industri As Process for preparing insulin esters
EP0085083B1 (en) 1981-08-10 1985-01-23 Nordisk Insulinlaboratorium Process for the enzymatic preparation of human insulin
US4601979A (en) 1981-09-15 1986-07-22 Nordisk Insulinlaboratorium Process for preparing human insulin or B-30 esters thereof
DK149824C (da) 1982-01-22 1987-03-16 Carlsberg Biotechnology Ltd Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyrer i insuliner
EP0087238A1 (en) 1982-02-08 1983-08-31 Biogen N.V. Am improved method for preparing human insulin from non-human insulin
DK347086D0 (da) 1986-07-21 1986-07-21 Novo Industri As Novel peptides
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
CA1339955C (en) * 1986-10-14 1998-07-14 Richard Eugene Heiney Process for transforming a human insulin precursor to human insulin
DE10075034I1 (de) 1987-02-25 2001-05-23 Novo Nordisk As Insulinderivate
US6011007A (en) 1993-09-17 2000-01-04 Novo Nordisk A/S Acylated insulin
AU682061B2 (en) 1993-09-17 1997-09-18 Novo Nordisk A/S Acylated insulin
KR20030004317A (ko) 1999-12-29 2003-01-14 노보 노르디스크 에이/에스 인슐린 선구물질 및 인슐린 선구물질 유사체의 제조 방법
KR20030004315A (ko) 1999-12-29 2003-01-14 노보 노르디스크 에이/에스 효모에서 개선된 발효 수율을 갖는 인슐린 선구물질 및인슐린 선구물질 유사체의 제조 방법
ATE381573T1 (de) 2000-04-14 2008-01-15 Univ Maryland Biotech Inst Verbesserte thermostabilität und temperaturresistenz von proteinen
US20040198960A1 (en) 2001-03-29 2004-10-07 Janoff Edward N Human monoclonal antibodies against capsular polysaccharides of streptococcus pneumoniae

Also Published As

Publication number Publication date
PL369447A1 (en) 2005-04-18
AU2002342597A8 (en) 2003-06-10
AU2002342597A1 (en) 2003-06-10
IL161358A (en) 2011-05-31
HU228934B1 (hu) 2013-06-28
HUP0500037A3 (en) 2010-01-28
JP4404631B2 (ja) 2010-01-27
ES2344448T3 (es) 2010-08-27
EP1448786A2 (en) 2004-08-25
CA2464616C (en) 2012-07-24
EP1448786B1 (en) 2010-04-14
CN1589328A (zh) 2005-03-02
KR100925381B1 (ko) 2009-11-09
JP2005509687A (ja) 2005-04-14
CA2464616A1 (en) 2003-05-30
WO2003044210A3 (en) 2004-03-25
PL210437B1 (pl) 2012-01-31
IL161358A0 (en) 2004-09-27
CN100424179C (zh) 2008-10-08
RU2004118503A (ru) 2005-06-10
ATE464390T1 (de) 2010-04-15
DE60236014D1 (de) 2010-05-27
KR20050044855A (ko) 2005-05-13
HUP0500037A2 (hu) 2005-03-29
RU2376379C2 (ru) 2009-12-20
WO2003044210A2 (en) 2003-05-30

Similar Documents

Publication Publication Date Title
BR0213583A (pt) Processo para preparar um composto de insulina, e, composto de insulina
BR0209491A (pt) Processo para preparar ácidos carboxìlicos e derivados destes
BRPI0516735B8 (pt) métodos para produção de (r)-2-acetamido-n-benzil-3-metoxipropionamida (lacosamida) e de uma formulação farmacêutica, e uso de (r)-n-benzil-2-nboc-amino-3-metoxipropionamida (c-937)
ATE409719T1 (de) Verfahren zur herstellung fester treibmittelpräparationen
DE60042375D1 (de) Verfahren zur Herstellung von 3,3-Dimethylbutanal
BR9809628A (pt) Processos para preparação de um composto e para a preparação de um aminoálcool.
ES2159919T3 (es) Procedimiento para la preparacion de compuestos de tipo ceramidas.
BR0311242A (pt) Processo para preparar modafinil
BR0309575A (pt) Processo para a preparação de uma solução aquosa de acrilato de metal alcalino, e, uso de uma solução aquosa de acrilato de metal alcalino
BR0000897A (pt) Processo para a produção fermentativa de l-aminoácidos usando-se bactéria corineforme
AR006058A1 (es) Procedimientos para preparar compuestos de dicianoacetato y de 1,2-pirazol-5-amino-3-substituido
AU2003291987A1 (en) Method for regenerating a hydrogenation catalyst
BR9908797A (pt) Aperfeiçoamento na sìntese enzimática de aminas quirais e método de preparação de (s)-1- metoxi-2-aminopropano
BR0012388A (pt) Preparação de uma bisoxazolina aromática
BRPI0409235A (pt) processo para a produção de sal de amÈnio do ácido 2-hidróxi-4-metiltiobutìrico
AU2001281883A1 (en) Method for producing 2-alkyl-3-aryl- and -heteroaryloxaziridines and novel 2-alkyl-3-aryloxaziridines
CY1106051T1 (el) ΔΙΑΔΙΚΑΣΙΑ ΓΙΑ ΤΗΝ ΠΑΡΑΓΩΓΗ Ν-ΠΡΟΣΤΑΤΕΥΜΕΝΩΝ ΑΖΕΤΙΔΙΝΟ-2-ΚΑΡΒΟΞΥΛΙΚΩΝ ΟΞΕΩΝ (AzeOHs)
BR0002493A (pt) Processo para a preparação de l-aminoácidos por fermentação e sequências de nucleotìdeos que codificam o gene accda
BR0117189A (pt) Processo para tratar um meio aquoso que contém oxima de ciclohexanona e ciclohexanona
SE0201938D0 (sv) New process
PT1019347E (pt) Metodo para a sintese de taxanos
CO5050334A1 (es) (7alfa, 17beta)-[[(trans-4-butilciclohexil)carbonil]oxi]-7- metilestr-4- en -3-ona (ment buciclato) y cicloalquil esteres relacionados que se usan para tratar la insuficien- cia de androgenos
DE60216616D1 (de) Enzymatisches verfahren zur herstellung von organofluorverbindungen
BR9909029A (pt) Estabilização de poliisocianatos orgânicos
BR9902525A (pt) Processo para compostos de ácido pirrolidinil-hidroxâmico

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: C12P 21/02

Ipc: C12P 21/02 (2006.01), C07K 14/62 (2006.01), A61K 3

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B10A Cessation: cessation confirmed

Free format text: HOMOLOGADA A DESISTENCIA DO PEDIDO SOLICITADA ATRAVES DA PETICAO NO 870180149807 DE 09/11/2018.